Clinical Trial Update: Recommended Dose Estimation of BP-C2 [Phase 1]

View source ↗

Summary

Phase 1 trial update describing the recommended dose estimation for BP-C2 in prostate cancer, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• BP-C2

Snippet

Sponsor: Meddoc | Conditions: Prostate Cancer | Phase 1 | Status: RECRUITING